Customized optical mapping by CRISPR-Cas9 mediated DNA labeling with multiple sgRNAs.
Alleles
Base Sequence
Benzoxazoles
/ analysis
CRISPR-Cas Systems
Chromosome Mapping
/ methods
Chromosomes, Bacterial
/ genetics
Computer Simulation
Conserved Sequence
/ genetics
DNA-Directed RNA Polymerases
Drug Resistance, Bacterial
/ genetics
Fluorescent Dyes
/ analysis
Gene Editing
/ methods
Genome, Bacterial
Genome, Human
Haemophilus influenzae
/ drug effects
Haplotypes
/ genetics
Humans
Lab-On-A-Chip Devices
Nalidixic Acid
/ pharmacology
Novobiocin
/ pharmacology
Nucleotide Motifs
/ genetics
Polymorphism, Single Nucleotide
Quinolinium Compounds
/ analysis
RNA, Guide, Kinetoplastida
/ chemical synthesis
Repetitive Sequences, Nucleic Acid
/ genetics
Sequence Alignment
Staining and Labeling
/ methods
Viral Proteins
Journal
Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011
Informations de publication
Date de publication:
25 01 2021
25 01 2021
Historique:
accepted:
27
10
2020
revised:
16
10
2020
received:
02
07
2020
pubmed:
25
11
2020
medline:
9
2
2021
entrez:
24
11
2020
Statut:
ppublish
Résumé
Whole-genome mapping technologies have been developed as a complementary tool to provide scaffolds for genome assembly and structural variation analysis (1,2). We recently introduced a novel DNA labeling strategy based on a CRISPR-Cas9 genome editing system, which can target any 20bp sequences. The labeling strategy is specifically useful in targeting repetitive sequences, and sequences not accessible to other labeling methods. In this report, we present customized mapping strategies that extend the applications of CRISPR-Cas9 DNA labeling. We first design a CRISPR-Cas9 labeling strategy to interrogate and differentiate the single allele differences in NGG protospacer adjacent motifs (PAM sequence). Combined with sequence motif labeling, we can pinpoint the single-base differences in highly conserved sequences. In the second strategy, we design mapping patterns across a genome by selecting sets of specific single-guide RNAs (sgRNAs) for labeling multiple loci of a genomic region or a whole genome. By developing and optimizing a single tube synthesis of multiple sgRNAs, we demonstrate the utility of CRISPR-Cas9 mapping with 162 sgRNAs targeting the 2Mb Haemophilus influenzae chromosome. These CRISPR-Cas9 mapping approaches could be particularly useful for applications in defining long-distance haplotypes and pinpointing the breakpoints in large structural variants in complex genomes and microbial mixtures.
Identifiants
pubmed: 33231685
pii: 5999906
doi: 10.1093/nar/gkaa1088
pmc: PMC7826249
doi:
Substances chimiques
Benzoxazoles
0
Fluorescent Dyes
0
Quinolinium Compounds
0
RNA, Guide
0
Viral Proteins
0
1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium
143413-85-8
Novobiocin
17EC19951N
Nalidixic Acid
3B91HWA56M
bacteriophage T7 RNA polymerase
EC 2.7.7.-
DNA-Directed RNA Polymerases
EC 2.7.7.6
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e8Subventions
Organisme : NHGRI NIH HHS
ID : R01 HG005946
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.
Références
Nat Biotechnol. 2012 Aug;30(8):771-6
pubmed: 22797562
Nucleic Acids Res. 2016 Jan 29;44(2):e11
pubmed: 26481349
Nat Rev Genet. 2006 Feb;7(2):85-97
pubmed: 16418744
Genomics. 1996 May 1;33(3):389-408
pubmed: 8660999
Nucleic Acids Res. 2007;35(3):e16
pubmed: 17175538
PLoS Pathog. 2011 Jul;7(7):e1002151
pubmed: 21829353
PLoS Genet. 2020 Jan 27;16(1):e1008347
pubmed: 31986135
Genome Res. 2017 Nov;27(11):1904-1915
pubmed: 29025896
PLoS One. 2014 May 29;9(5):e98186
pubmed: 24873830
Bioinformatics. 2019 Jul 1;35(13):2193-2198
pubmed: 30462145
Nat Methods. 2009 Mar;6(3):199-201
pubmed: 19198595
G3 (Bethesda). 2014 Apr 16;4(4):717-31
pubmed: 24569039
J Am Chem Soc. 2007 Mar 14;129(10):2758-9
pubmed: 17309265
J Biotechnol. 2015 Oct 10;211:56-65
pubmed: 26189696
BMC Genomics. 2020 Jul 15;21(1):485
pubmed: 32669102
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Genome Res. 1995 Aug;5(1):1-4
pubmed: 8717049
Nature. 2015 Oct 1;526(7571):75-81
pubmed: 26432246
Genome Res. 2019 Sep;29(9):1389-1401
pubmed: 31481461
Nat Commun. 2019 Mar 4;10(1):1025
pubmed: 30833565
Bioinformatics. 2008 May 15;24(10):1229-35
pubmed: 18356192
Genome Biol. 2020 Feb 7;21(1):30
pubmed: 32033565
BMC Genomics. 2009 Jan 15;10:25
pubmed: 19146697
Nature. 2020 Sep;585(7823):79-84
pubmed: 32663838
Nucleic Acids Res. 2017 May 19;45(9):e73
pubmed: 28180280
Sci Rep. 2016 Dec 01;6:37938
pubmed: 27905467
BMC Genomics. 2007 Sep 14;8:321
pubmed: 17868451
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4338-44
pubmed: 8506271
Nat Biotechnol. 2013 Feb;31(2):135-41
pubmed: 23263233
PLoS Biol. 2009 May 5;7(5):e1000112
pubmed: 19468303
Science. 2005 Apr 22;308(5721):554-7
pubmed: 15845853
Infect Immun. 2007 Feb;75(2):958-65
pubmed: 17130253
Methods Mol Med. 2003;71:51-6
pubmed: 12374030
Nature. 2007 Oct 18;449(7164):851-61
pubmed: 17943122
Nat Biotechnol. 2018 Apr;36(4):338-345
pubmed: 29431738
Genome Res. 2014 Jan;24(1):132-41
pubmed: 24253446
Sci Rep. 2014 Jun 23;4:5405
pubmed: 24956376
PLoS Genet. 2009 Nov;5(11):e1000711
pubmed: 19936062
Methods Mol Med. 2003;71:57-70
pubmed: 12374031
Nat Commun. 2019 Apr 16;10(1):1784
pubmed: 30992455
Genetics. 2016 Jan;202(1):351-62
pubmed: 26510793
Science. 1995 Jul 28;269(5223):496-512
pubmed: 7542800
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5225-30
pubmed: 9144219
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8046-51
pubmed: 9653137
Biotechniques. 2017 Jun 1;62(6):255-267
pubmed: 28625155
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10848-53
pubmed: 20534489
Nat Biotechnol. 2013 Sep;31(9):833-8
pubmed: 23907171